The current financial score of Orthofix Medical Inc is 7.11. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 210.93M, representing a year-over-year increase of 3.85%, while its net profit experienced a year-over-year increase of 12.19%.
The current valuation score of Orthofix Medical Inc is 8.46. Its current P/E ratio is -5.99, which is -58.36% below the recent high of -2.50 and -285.61% above the recent low of -23.11.
The current earnings forecast score of Orthofix Medical Inc is 8.00. The average price target is 13.00, with a high of 14.00 and a low of 12.00.
The current price momentum score of Orthofix Medical Inc is 4.00. Currently, the stock price is trading between the resistance level at 10.24 and the support level at 8.13, making it suitable for range-bound swing trading.
The current institutional shareholding score of Orthofix Medical Inc is 10.00. The latest institutional shareholding proportion is 94.72%, representing a quarter-over-quarter increase of 4.24%. The largest institutional shareholder is James Simons, holding a total of 96.79K shares, representing 0.00% of shares outstanding, with 46.37% decrease in holdings.
The current risk assessment score of Orthofix Medical Inc is 6.83. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.